Erschienen in:
01.04.2020 | Head and Neck
Long-term management of patients with PFAPA syndrome
verfasst von:
Erkan Yıldız, Selçuk Kuzu, Orhan Kemal Kahveci, Şahin Ulu, Abdulkadir Bucak
Erschienen in:
European Archives of Oto-Rhino-Laryngology
|
Ausgabe 8/2020
Einloggen, um Zugang zu erhalten
Abstract
Objective
To evaluate the long-term treatment results of patients with PFAPA syndrome and to determine their need for tonsillectomy.
Materials and methods
The clinical characteristics, treatments and long-term results of 16 patients admitted to the Pediatric and Otorhinolaryngology Clinic between 2015 and 2019 were retrospectively analyzed.
Results
Twelve male and four female patients were examined between 1.5 and 8 years (mean age 4.8 ± 1.1) (75% male, 25% female). The mean duration of attacks was 4.4 ± 1.4 weeks. Twelve patients recovered completely with single-dose steroid therapy. In the 4-year follow-up of 12 patients who were given a single dose of steroid therapy, there were no relapses. Surgical decisions were made for four patients whose attacks did not pass with steroid treatment. Two patients (75%) underwent adenotonsillectomy, and one patient underwent tonsillectomy While three of these patients did not have an attack again, one patient continued to have an attack every 8 weeks. At the age of 9, his attacks were completely resolved spontaneously. All patients had fever. The most common concomitant symptoms were pharyngitis (94%), cervical adenitis (82%) and aphthous stomatitis (77%). Exudative tonsillitis was present in 25% of the patients.
Conclusion
Medical treatment should be the first treatment option in patients with PFAPA syndrome. Although single-dose steroid treatment is effective in these patients, tonsillectomy is an important treatment option in refractory cases.